ANEB vs SHW · $15.3M cap vs P/E 29, rev $12.46B
Anebulo Pharmaceuticals Inc (ANEB) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Anebulo Pharmaceuticals Inc (ANEB) is a biotechnology company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
ANEB does not have a complete income-statement cache yet.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
ANEB currently screens at market cap $15.3M. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the ANEB and SHW stock pages for the full models.
Not investment advice.